Northwest & Ethical Investments L.P. Has $13.55 Million Holdings in Zoetis Inc. $ZTS

Northwest & Ethical Investments L.P. raised its holdings in Zoetis Inc. (NYSE:ZTS) by 266.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 86,890 shares of the company’s stock after acquiring an additional 63,151 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Zoetis were worth $13,550,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Nuveen LLC bought a new stake in shares of Zoetis during the first quarter worth $616,375,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Zoetis by 113.0% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock valued at $586,671,000 after purchasing an additional 1,995,491 shares during the period. Polen Capital Management LLC lifted its holdings in shares of Zoetis by 17.6% in the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after purchasing an additional 1,313,653 shares in the last quarter. Impax Asset Management Group plc boosted its position in shares of Zoetis by 362.6% during the second quarter. Impax Asset Management Group plc now owns 1,176,996 shares of the company’s stock worth $182,705,000 after buying an additional 922,589 shares during the period. Finally, Amundi grew its holdings in shares of Zoetis by 30.8% during the first quarter. Amundi now owns 3,595,628 shares of the company’s stock worth $575,691,000 after buying an additional 846,909 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on ZTS shares. KeyCorp assumed coverage on Zoetis in a research note on Thursday, November 20th. They issued a “sector weight” rating on the stock. UBS Group reduced their target price on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Argus reiterated a “buy” rating and issued a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Piper Sandler boosted their price target on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Zoetis presently has a consensus rating of “Moderate Buy” and a consensus target price of $178.89.

Zoetis Trading Up 4.1%

Shares of NYSE:ZTS opened at $127.85 on Wednesday. Zoetis Inc. has a 52-week low of $115.25 and a 52-week high of $181.85. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The company has a market capitalization of $56.34 billion, a P/E ratio of 22.01, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a 50-day simple moving average of $136.89 and a 200 day simple moving average of $149.63.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same quarter in the prior year, the company earned $1.58 earnings per share. The business’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a yield of 1.6%. Zoetis’s dividend payout ratio (DPR) is currently 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.